Bain Capital Public Equity Management Ii, LLC Bristol Myers Squibb CO Put Options Transaction History

Bain Capital Public Equity Management Ii, LLC

$2.33 Billion
Q1 2024

Put Options

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $226,366 - $295,274	-4,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $196,742 - $233,266	4,600 New	4,600 $221,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

Vanguard Group Inc Valley Forge, PA

186M
Shares

$7.38 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

163M
Shares

$6.45 Billion
0.21% of portfolio
State Street Corp Boston, MA

91.6M
Shares

$3.63 Billion
0.23% of portfolio
Jpmorgan Chase & CO New York, NY

88.8M
Shares

$3.52 Billion
0.44% of portfolio
Capital International Investors Los Angeles, CA

70.2M
Shares

$2.78 Billion
0.79% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account